Irazoqui Fernando J, Lopez Pablo H H, Mandel Ulla, Nores Gustavo A
Departamento de Química Biológica, CIQUIBIC-CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, 5000 Córdoba, Argentina.
Mol Immunol. 2002 Mar;38(11):825-31. doi: 10.1016/s0161-5890(01)00123-7.
Aberrant O-glycosylation of cell surface mucin antigens is characteristic of epithelial cancer cells. For example, Thomsen-Friedenreich disaccharide (TFD) is a chemically well-defined carbohydrate antigen with a documented link to malignancy. There have been many attempts to improve immune response to carbohydrate antigens, for use in immunotherapy. As part of an alternative strategy to improve carbohydrate immunogenicity, we studied the influence of terminal benzyl (Bzl) or p-nitrophenyl (pNP) residue on immunogenicity of adjacent TFD. Mice immunized with keyhole limpets hemocyanin-TFD (KLH-TFD), KLH-TFD(alpha)Bzl, or KLH-TFD(alpha)pNP produced anti-KLH antibodies, which were analyzed by enzyme-linked immunosorbent assay (ELISA). KLH-TFD did not give significant anti-TFD antibody titer, confirming the poor immunogenicity of TFD. Immunization with KLH-TFD(alpha)Bzl and KLH-TFD(alpha)pNP raised antibody titers against TFD(alpha)Bzl and TFD(alpha)pNP, respectively. KLH-TFD(alpha)Bzl also gave higher anti-TFD antibody response, whereas KLH-TFD(alpha)pNP did not, indicating that terminal Bzl residue improves immune response to adjacent carbohydrate. Analysis of anti-TFD(alpha)Bzl or anti-TFD(alpha)pNP IgG antibodies by competitive ELISA, using carbohydrate-related antigens as inhibitors, demonstrated their high specificity to their respective antigens. Anti-TFD(alpha)pNP antibody was not inhibited by TFD, but was significantly inhibited by GalNAc(alpha)pNP. The fact that p-nitrophenol (pNPol) has more competitive ability that GalNAc indicates that terminal polar residue is the main target antigen. In contrast, anti-TFD(alpha)Bzl antibody was inhibited to a similar degree by GalNAc(alpha)Bzl and TFD, confirming the carbohydrate recognition by antibodies yielded by terminal non-polar modification of the immunogen.
细胞表面黏蛋白抗原的异常O-糖基化是上皮癌细胞的特征。例如,Thomsen-Friedenreich二糖(TFD)是一种化学结构明确的碳水化合物抗原,与恶性肿瘤有明确关联。为了用于免疫治疗,人们进行了许多尝试来改善对碳水化合物抗原的免疫反应。作为提高碳水化合物免疫原性的替代策略的一部分,我们研究了末端苄基(Bzl)或对硝基苯基(pNP)残基对相邻TFD免疫原性的影响。用钥孔血蓝蛋白-TFD(KLH-TFD)、KLH-TFD(α)Bzl或KLH-TFD(α)pNP免疫的小鼠产生了抗KLH抗体,通过酶联免疫吸附测定(ELISA)对其进行分析。KLH-TFD未产生显著的抗TFD抗体效价,证实了TFD免疫原性较差。用KLH-TFD(α)Bzl和KLH-TFD(α)pNP免疫分别提高了针对TFD(α)Bzl和TFD(α)pNP的抗体效价。KLH-TFD(α)Bzl也产生了更高的抗TFD抗体反应,而KLH-TFD(α)pNP则没有,这表明末端Bzl残基改善了对相邻碳水化合物的免疫反应。使用碳水化合物相关抗原作为抑制剂,通过竞争性ELISA分析抗TFD(α)Bzl或抗TFD(α)pNP IgG抗体,证明它们对各自抗原具有高度特异性。抗TFD(α)pNP抗体未被TFD抑制,但被GalNAc(α)pNP显著抑制。对硝基苯酚(pNPol)比GalNAc具有更强竞争能力这一事实表明,末端极性残基是主要的靶抗原。相反,抗TFD(α)Bzl抗体被GalNAc(α)Bzl和TFD抑制的程度相似,证实了免疫原末端非极性修饰产生的抗体对碳水化合物的识别。